Skip to main content

. 1971 Oct;43(2):457P–458P.

Vascular changes in tumours after treatment with ICRF 159.

A W Le Serve, K Hellmann

PMCID: PMC1665898 PMID: 5158233

458P

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Burrage K., Hellmann K., Salsbury A. J. Drug-induced inhibition of tumour cell dissemination. Br J Pharmacol. 1970 May;39(1):205P–206P. [PMC free article] [PubMed] [Google Scholar]
Hellmann K., Burrage K. Control of malignant metastases by ICRF l59. Nature. 1969 Oct 18;224(5216):273–275. doi: 10.1038/224273a0. [DOI] [PubMed] [Google Scholar]
MAJNO G., PALADE G. E., SCHOEFL G. I. Studies on inflammation. II. The site of action of histamine and serotonin along the vascular tree: a topographic study. J Biophys Biochem Cytol. 1961 Dec;11:607–626. doi: 10.1083/jcb.11.3.607. [DOI] [PMC free article] [PubMed] [Google Scholar]
Salsbury A. J., Burrage K., Hellmann K. Inhibition of metastatic spread by I.C.R.F. 159: selective deletion of a malignant characteristic. Br Med J. 1970 Nov 7;4(5731):344–346. doi: 10.1136/bmj.4.5731.344. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

PDF (257.1 KB)

RESOURCES